Noel Jackson, the Sr. Vice President of $CPSS, sold 9,369 shares of the company on 09-16-2025 for an estimated $79,578. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $CPSS stock.
$CPSS Insider Trading Activity
$CPSS insiders have traded $CPSS stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CPSS stock by insiders over the last 6 months:
- GREG WASHER has made 0 purchases and 7 sales selling 25,689 shares for an estimated $251,080.
- NOEL JACKSON (Sr. Vice President) sold 9,369 shares for an estimated $79,578
- APRIL CRISP (Sr. Vice President) sold 100 shares for an estimated $975
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CPSS Hedge Fund Activity
We have seen 23 institutional investors add shares of $CPSS stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HIGHPOINT ADVISOR GROUP LLC added 33,343 shares (+31.0%) to their portfolio in Q2 2025, for an estimated $327,761
- GOLDMAN SACHS GROUP INC removed 18,949 shares (-59.7%) from their portfolio in Q2 2025, for an estimated $186,268
- CITADEL ADVISORS LLC removed 18,176 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $178,670
- GEODE CAPITAL MANAGEMENT, LLC added 16,563 shares (+8.5%) to their portfolio in Q2 2025, for an estimated $162,814
- BLACKROCK, INC. added 12,548 shares (+2.0%) to their portfolio in Q2 2025, for an estimated $123,346
- RENAISSANCE TECHNOLOGIES LLC removed 9,400 shares (-2.3%) from their portfolio in Q2 2025, for an estimated $92,402
- BARCLAYS PLC added 6,941 shares (+74.7%) to their portfolio in Q2 2025, for an estimated $68,230
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
